Group III related healthy individuals based on their clinical observation,
without evidence of contact with S. stercoralis infection or previous
history of strongyloidiasis and three fecal samples tested negative.
This study was approved, in 2013, by the Ethics Committee of the
Universidade Federal de Uberlândia (UFU), State of Minas Gerais,
Brazil, protocol number 307.605.